UroPharma Inc – US Head Quarters
Howard Shapland – President and CEO
Howard is a marketing and business development executive with BioVenture Development Limited and a certified Lead Auditor for ISO 13485:2016. He holds a Diploma in Business Studies and has formal training in business development, marketing & business management as well as product & project development – primarily in the biotechnology industry. He has over 25 years’ experience in the field. For 15 years he held senior positions with the multinational pharmaceutical company Abbott Laboratories (US). During this time, he was based in Australia, Europe and the Middle East.
Howard established BioVenture Development in 2009. The company provides regulatory & compliance consultancy, business & project development in the biotechnology sector. Howard has worked with International Medical Devices PLC, as Regulatory and Compliance Manager to introduce ISO 9001 and ISO 13485 quality management systems to the group, CE Mark medical devices and maintaining regulatory compliance.
Professor Scott Glickman – Chairman and Chief Medical Officer
Professor Scott Glickman FRCS is a rehabilitation physician in the UK, with over 35 years in clinical practice. He set up The Academic Medical Rehabilitation Unit in Imperial College School of Medicine and has extensive community-based rehabilitation experience working in both England and Scotland. His specialist interests include multiple sclerosis, traumatic brain and spinal cord injuries and neuro-urology, colonic function and spasticity. His research publications are broad-based in these fields.
Regarding healthcare technology Scott is an award winner and has produced several patented inventions. He was an assessor for i4i, a UK government healthcare technology grants funding body and an assessor for the development of government-funded healthcare technology cooperatives as well as a research grant reviewer for The MS Society of Great Britain and Northern Ireland. Scott was a founder and trustee of both ASPIRE, a UK national spinal cord injury charity, and MOTIVATION, an international healthcare technology provider charity.
Brett M. Larson – General Counsel
Brett M. Larson is a Shareholder with Messerli Kramer and is Chair of the Business Services group which oversees the Corporate, Banking & Finance, and Intellectual Property & Technology practice groups. Brett focuses his practice in the areas of corporate governance and succession planning; mergers and acquisitions; and domestic and international transactions Brett serves as outside counsel to businesses of all sizes—from emerging growth companies to large global corporations in a range of health care industries including med-tech and bio-tech. Having represented numerous clients in business disputes, he leverages his experience and background as lead-counsel in a broad range of complex litigation and transactional settings to develop sound business and legal strategies aimed at avoiding litigation, and having a well-prepared plan when necessary. Brett serves on the firm’s Board of Directors and as an advisor to the boards of multiple nonprofit organizations.
Terry Kapsen – Vice President Business Development
Senior Executive / Entrepreneur in Medical Devices and Health & Fitness. Terry is a seasoned leader of hardware/software engineering, global sales, marketing, manufacturing, and service teams through start-up, growth, and exit stages of business. Terry Co-founded New Leaf Health and Fitness, a consumer products and services business aimed at providing personalized programs for weight management, cardiovascular programs for weight management, cardiovascular fitness, and athletic performance that was acquired by a major North American health and fitness chain.